Our #1 “Strong Buy” Biotech

Unsubscribe     Fellow Investor,   Many biotech companies have seen unfair drops in share price due to a broader market sell-off.   Novavax is down 67% YTD...   Moderna dropped 42.5% this year...   BioNTech lost 31% so far...   The biotech sector (XBI) as a whole is down about 40% YTD.   But while other investors are panicking, I'm looking at the opportunity.   There's a tiny biotech...trading at just $10 a share...   That's largely unknown to retail investors, but institutional investors are grabbing shares hand over fist.   Vanguard alone owns 12 million shares   BlackRock bought 6 million shares   J.P. Morgan bought 1.3 million shares   And it's not too late for you to get it in early too.   I've put together this quick presentation about this 46,751% gain opportunity.   Everything you need to know about this revolutionary biotech can be found right here.   "The Buck Stops Here,"   Dylan Jovine CEO & Founder, Behind the Markets   P.S. Make sure to get in ASAP while the stock is still undervalued. It had previously reached a $90 high!

This email was sent to stevenmagallanes520.nims@blogger.com by editor@marketmovingtrends.com CLM LLC c/o MarketMovingTrends, 45 South Park Place, #203, Morristown, NJ 07960 United States   Unsubscribe | Report Spam